x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:21:04

From Oxford: Professor Matthew Wood describes the...

BiotechTV - News ·

2026/02/17

He highlights the centre's Scholars program, which researchers anywhere can apply for and funds ten new drug development programs each year. Plus the centre's accelerator program and plans for a rare disease investment fund. He also discusses how regulatory changes at places like MHRA can help the rare disease community.

en-us

00:42:26

Biotech CEOs discuss the state of the industry, what...

BiotechTV - News ·

2026/02/13

MassBio President & CEO Kendalle Burlin O'Connell moderates a discussion with Aurora Therapeutics CEO Ed Kaye and DaCapo Brainscience CEO Leslie Williams about being biotech leaders during this volatile time for the industry. They stress that a key to success is that everyone in the industry work together towards shared goals.

en-us

00:18:55

Analyst Thursdays: Mizuho Senior Biotech Analyst...

BiotechTV - News ·

2026/02/12

He discusses upcoming readouts for IDEAYA Biosciences, Ocular Therapeutix (how it might affect EyePoint), and Palvella Therapeutics. Plus, his take on the recent Corvus atopic dermatitis data.

en-us

00:13:13

Upstream Bio's CEO Rand Sutherland discusses today's...

BiotechTV - News ·

2026/02/11

He describes top-line data the company saw across three different doses, next steps, and also shares an update on additional indications of chronic rhinosinusitis with nasal polyps and COPD it is being developed for.

en-us

00:27:18

Corvus Pharma CEO Richard Miller fields follow-up...

BiotechTV - News ·

2026/01/28

He discusses learnings about durability, dosing, biomarkers, and more for this first-in-class target.

en-us

00:16:46

Analysts Thursdays: Clear Street Senior Biotech...

BiotechTV - News ·

2026/01/22

She discusses Arrivent Biopharma, Oruka Therapeutics, Jade Biosciences, Zura Bio, and Pavella Therapeutics.

en-us

00:11:28

SF Healthcare Week: Perceptive Advisors' Joe Edelman,...

BiotechTV - News ·

2026/01/17

He talks about Perceptive's investment philosophy, his take on the year ahead, areas he thinks are over and under hyped, and thoughts on China. Plus, the rationale for a few of his top holdings.

en-us

00:11:55

SF Healthcare Week: Cytokinetics CEO Robert Blum...

BiotechTV - News ·

2026/01/16

He discussed the REMS, launch plans, market opportunity, payors, and the metrics that the company will offer publicly over time. Plus, previewing a key new data readout that will be coming in the second quarter of this year.

en-us

00:10:51

SF Healthcare Week: Sana Bio's CEO Steve Harr...

BiotechTV - News ·

2026/01/16

He describes one patient data from an investigator led study in Europe, and explains how Sana's program is slighly different. The company aims to file an IND this year. Plus, discussing the company's unique delivery mechanism for in vivo CAR-T.

en-us

00:13:04

SF Healthcare Week: Alumis' CEO Martin Babler walks...

BiotechTV - News ·

2026/01/15

He discusses the TYK2 landscape and describes why Alumis believes TYK2 can be a broad class in immunology.

en-us

00:10:04

SF Healthcare Week: CEO Heather Turner tells us about...

BiotechTV - News ·

2026/01/15

She walks us through LB-102, a methylated derivative of amisulpride, a therapy that has a history of success in Europe. Plus, her thoughts on the obesity market (she was CEO of Carmot Therapeutics at the time of its acquisition by Roche) and being a member of the Biotech CEO Sisterhood.

en-us

00:14:24

SF Healthcare Week: Neurocrine Biosciences CEO Kyle...

BiotechTV - News ·

2026/01/15

Plus, how the neuroscience company has used its long history working with corticotropin releasing factor to move into obesity, with a project that acts on targets in the brain.

en-us

00:17:11

SF Healthcare Week: Recursion's new CEO Najat Khan...

BiotechTV - News ·

2026/01/15

Najat Khan describes the impact Recursion's work is having, such the surprising PoC of using MEK1/2 inhibition as a target for treating Familial Adenomatous Polyposis (PAP). Plus, she discusses other programs and large-pharma partnerships, and using new tools such as Boltz-2.

en-us

00:14:19

SF Healthcare Week: Wave Life Sciences CEO Paul Bolno...

BiotechTV - News ·

2026/01/15

He describes the 'best-in-class' profile he believes INHBE can show in the obesity space. Plus the latest on other programs and how Wave is working on a new a new bifunctional modality.

en-us

00:09:21

SF Healthcare Week: Roivant CEO Matt Gline provides...

BiotechTV - News ·

2026/01/15

He discusses key data in the year ahead including from Immunovant and Priovant. Plus, an update on the lawsuits regarding covid vaccine LNP delivery IP and how he thinks about Roivant's cash balance.

en-us

00:09:21

SF Healthcare Week: Astellas Pharma CEO Naoki Okamura...

BiotechTV - News ·

2026/01/15

He talks about KRAS degraders, claudin 18.2, AAV gene therapy, and more. Plus, how Astellas thinks about the coming patent expiry of Xtandi.

en-us

00:10:10

SF Healthcare Week: Soleno Therapeutics' Chairman &...

BiotechTV - News ·

2026/01/15

He describes the launch, physician and patient feedback, and responds in his own words to short seller criticism.

en-us

00:11:27

SF Healthcare Week: Madrigal CEO Bill Sibold talks...

BiotechTV - News ·

2026/01/14

He discusses the rationale behind acquiring a DGAT-2 and GLP-1, and how a non-pharma sized company has been able to succeed with a new drug launch.

en-us

00:09:10

SF Healthcare Week: Insmed CEO Will Lewis discusses...

BiotechTV - News ·

2026/01/14

He discusses the $145M 4Q number that was announced at JPM, and the real world feedback the company has been receiving from physicians and patients. Plus, how the thinks about Insmed now that it is a $35B market cap company.

en-us

00:10:29

SF Healthcare Week: Beam's CEO John Evans shares an...

BiotechTV - News ·

2026/01/12

He discusses regulatory feedback the company has received that might allow it to earn an accelerated approval in antitrypsin deficiency. Plus, filing for sickle cell later this year, and how he thinks about new targets.

en-us

408 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter